The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients-Reference-Cited by-同舟云学术

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

Published:2014-02-19 Issue:9 Volume:28 Page:1804-1810
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Guglielmelli P,Lasho T L,Rotunno G,Score J,Mannarelli C,Pancrazzi A,Biamonte F,Pardanani A,Zoi K,Reiter A,Duncombe A,Fanelli T,Pietra D,Rumi E,Finke C,Gangat N,Ketterling R P,Knudson R A,Hanson C A,Bosi A,Pereira A,Manfredini R,Cervantes F,Barosi G,Cazzola M,Cross N C P,Vannucchi A M,Tefferi A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201476.pdf

Reference21 articles.

1. Vannucchi AM, Guglielmelli P, Tefferi A . Advances in understanding and management of myeloproliferative neoplasms. CA Cancer J Clin 2009; 59: 171–191.

2. Cervantes F, Dupriez B, Passamonti F, Vannucchi AM, Morra E, Reilly JT et al. Improving survival trends in primary myelofibrosis: an International Study. J Clin Oncol 2012; 30: 2981–2987.

3. Cervantes F, Dupriez B, Pereira A, Passamonti F, Reilly JT, Morra E et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for myelofibrosis research and treatment. Blood 2009; 113: 2895–2901.

4. Passamonti F, Cervantes F, Vannucchi AM, Morra E, Rumi E, Pereira A et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood 2010; 115: 1703–1708.

5. Gangat N, Caramazza D, Vaidya R, George G, Begna K, Schwager S et al. DIPSS Plus: a refined dynamic international prognostic scoring system for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol 2011; 29: 392–397.

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presence of triple positive driver mutations in JAK2, CALR and MPL in primary myelofibrosis: a case report and literature review;Hematology;2024-09-13

2. IDH2 mutation accelerates TPO‐induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo;eJHaem;2024-07-28

3. Function of serine/arginine-rich splicing factors in hematopoiesis and hematopoietic malignancies;Cancer Cell International;2024-07-21

4. Immunofluorescence microscopy on the blood smear identifies patients with myeloproliferative neoplasms;Leukemia;2024-07-17

5. SOHO State of the Art Updates and Next Questions | Diagnosis, Outcomes, and Management of Prefibrotic Myelofibrosis;Clinical Lymphoma Myeloma and Leukemia;2024-07